Butyrate-Induced Differentiation of Colon Cancer Cells Is PKC and JNK Dependent
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Butyric acid, a short-chain fatty acid physiologically present in human large gut, is derived from bacterial fermentation of complex carbohydrates. It has been shown to reduce the growth and motility of colon cancer cell lines and to induce cell differentiation and apoptosis. Apoptosis is considered a result of normal colonocyte terminal differentiation in vivo. The aim of this study was to characterize the cellular mechanisms regulating differentiation of colon cancer cells stimulated with sodium butyrate (NaB). The two human colon cancer cell lines Caco-2 and HT-29 were treated with NaB at physiologically relevant concentrations. Alkaline phosphatase (ALP) activity, a marker of colonocyte differentiation, was increased 48 hr after treatment with 1 mM NaB. Higher doses of NaB (5 and 10 mM) induced apoptosis of the cells and failed to stimulate the colonocyte differentiation. Therefore, we assumed that butyrate augments cell differentiation and induces apoptosis, acting via various intracellular mechanisms, and butyrate-mediated programmed cell death cannot be considered a consequence of colonocyte terminal differentiation. The effect of NaB on ALP activity was significantly attenuated in the presence of inhibitors of protein kinase C and JNK. Inhibition of MEK-ERK signal transduction pathways augmented the impact of butyrate on colonocyte differentiation. These results suggest that butyrate could influence the colonocyte differentiation via modulation of the activity of cellular protein kinases and signal transduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other agents, including bone morphogenetic protein 4 (BMP4) and some HDAC inhibitors, have also been shown to promote differentiation of colorectal CSCs and increase their response to chemotherapy [207,208,209].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [208]
Citations
Cites
1 retracted
Schwartz, B., Avivi-Green, C., & Polak‐Charcon, S. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006831330340 · Cited by 63
RetractedBradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Pinto, M. (1983) · HAL · Cited by 1,752
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man.
Roediger, W. E. (1980) · Gut · doi:10.1136/gut.21.9.793 · Cited by 1,310
Utilization of Nutrients by Isolated Epithelial Cells of the Rat Colon
Roediger, W. E. W. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80339-9 · Cited by 1,191
Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis
Hall*, P. A., Coates, P. J., Ansari, B., & Hopwood, D. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.12.3569 · Cited by 816
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
Archer, S. Y., Meng, S., Shei, A., & Hodin, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6791 · Cited by 535
Bursch, W., Paffe, S., Putz, B., Barthel, G., & Schulte-Hermann, R. (1990) · Carcinogenesis · doi:10.1093/carcin/11.5.847 · Cited by 444
Research works printed but not linked: 5
- Kim YS, Gum JR, Ho SB, Deng G: Colonocyte differentiation and proliferation: overview and the butyrate-induced transcriptional regulation of oncodevelopmental placental-like alkaline phosphatase gene in colon cancer cells. In Short Chain Fatty Acids, Falk Symposium 73. HJ Binder, J Cummings, KH Soergel (eds). Dordrecht, Kluwer Academic Press, 1993, pp 119–134
- Wolin MJ: Control of short chain volatile acid production in the colon. In Short Chain Fatty Acids, Falk Symposium 73. HJ Binder, J Cummings, KH Soergel (eds). Dordrecht, Kluwer Academic Press, 1993, pp 3–10
- Young GP, Gibson PR: Butyrate and the colorectal cancer cell. In Short Chain Fatty Acids, Falk Symposium 73. HJ Binder, J Cummings, KH Soergel (eds). Kluwer Academic Press, Dordrecht, 1993, pp 148–160
- Dzierzewicz Z, Kwapisz I, Cwalina B, Wilczok T: The role of butyric acid in growth, proliferation and differentiation of colonocytes. Gastroenterol Pol 6:153–159, 1999
- Rickard KL, Gibson PR, Wilson NJ, Mariadason JM, Phillips WA: Short-chain fatty acids reduce expression of specific protein kinase C isoforms in human colonic epithelial cells. J Cell Physiol 182:222–231, 2000 · DOI
Cited by
Yu, L. C.-H. (2012) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v3.i1.27 · Cited by 270
Azcárate-Peril, M. A., Sikes, M., & Bruno-Bárcena, J. M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00110.2011 · Cited by 253
“Additionally, butyrate possesses possible anticarcinogenic effects by suppressing the COX-2 expression in HT-29 and in Caco-2 cancer cell lines (190, 261) and promoting expression of differentiation markers such as alkaline phosphatase in colonic cell lines (78, 196).”
BackgroundEffects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
Chen, J., Zhao, K.-N., & Vitetta, L. (2019) · Nutrients · doi:10.3390/nu11051026 · Cited by 198
“It has been shown in HT-29 and HCT8 cells, GPR3 activation caused cell cycle arrest and increased p21 levels and decreased levels of cyclin D3 and cyclin-dependent kinases (CDKs) 1 and 2 [108].”
BackgroundInfluentialButyrate and Colorectal Cancer: The Role of Butyrate Transport
Gonçalves, P., & Martel, F. (2013) · Current Drug Metabolism · doi:10.2174/1389200211314090006 · Cited by 179
Lamas, B., Martins Breyner, N., & Houdeau, E. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00349-z · Cited by 174
Metadata
- Authors
- Orchel, A., Dzierżewicz, Z., Parfiniewicz, B., Weglarz, L., & Wilczok, T.
- Affiliations
- Medical University of Silesia (PL)
- Corresponding author
- Orchel, Arkadiusz
- Venue
- Digestive Diseases and Sciences
- Published
- 2005-03
- Volume
- 50
- Issue
- 3
- Pages
- 490-498
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2078297169
- Cited by
- 95
- References
- 56
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 2 · 2014: 7 · 2013: 4 · 2012: 8
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- sodium butyrate, colon cancer, cell differentiation, apoptosis, protein kinase C, JNK, MEK/ERK signaling, alkaline phosphatase activity, short-chain fatty acids, Caco-2 cells, HT-29 cells, signal transduction
- MeSH terms
- Butyrates, Cell Differentiation, Cell Survival, Colonic Neoplasms, Enzyme Activation, Humans, Protein Kinase C, Sensitivity and Specificity, Tumor Cells, Cultured, Signal Transduction, Apoptosis, Caco-2 Cells, HT29 Cells, JNK Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Butyrate-Induced Differentiation of Colon Cancer Cells Is PKC and JNK Dependent. https://app.cochat.ai/papers/10.1007/s10620-005-2463-6
- The paper
- Orchel, A., Dzierżewicz, Z., Parfiniewicz, B., Weglarz, L., & Wilczok, T. (2005). Butyrate-Induced Differentiation of Colon Cancer Cells Is PKC and JNK Dependent. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-005-2463-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.